spec sheet10 rows
3α-Androstanediol (5α-androstane-3α,17β-diol) is an endogenous neurosteroid formed as the terminal 3α-reduced metabolite of dihydrotestosterone (DHT, the most potent natural androgen). Despite its androgenic origin it binds the androgen receptor only weakly; its defining pharmacology is potent positive allosteric modulation of the GABA-A receptor (the brain's principal inhibitory chloride ion channel), which produces anxiolytic (anxiety-reducing) and anticonvulsant (seizure-suppressing) effects in animal models. It is widely regarded as the androgenic counterpart of allopregnanolone (the analogous progesterone-derived neurosteroid), and is proposed to mediate much of the influence that testosterone exerts on seizure threshold, anxiety, and mood in males. It additionally acts as a ligand of estrogen receptor beta (ERβ), which may underlie some of its cognitive and neuroprotective actions.
- Positive allosteric modulation of GABA-A receptors, producing anxiolytic (anxiety-reducing) effects in rodent models
- Anticonvulsant activity that raises seizure threshold in animal models of epilepsy
- Proposed mediator of the antiseizure, anxiolytic, and mood effects attributed to testosterone in males
- Possible support of hippocampal learning and memory, partly through estrogen receptor beta
- Acts as a metabolic reservoir that buffers dihydrotestosterone levels in brain and peripheral tissue
- Sedation and motor impairment at high GABAergic doses in animal studies
- Potential tolerance, dependence, and withdrawal phenomena common to GABA-A modulating neurosteroids
Overview
The androgen-derived GABA-A positive allosteric modulator; a DHT metabolite that behaves like allopregnanolone rather than a classic androgen.
- Although it is derived from the potent androgen DHT, 3α-androstanediol binds the androgen receptor only weakly; its 3α-hydroxyl group instead gives it allopregnanolone-like activity at GABA-A receptors.
- It is often called the androgenic counterpart of allopregnanolone, and was proposed as the mechanistic link explaining why testosterone raises seizure threshold and reduces anxiety in male animals.
- The conversion of DHT to 3α-androstanediol is reversible, so the metabolite is a bidirectional reservoir that can regenerate active DHT through 3α-hydroxysteroid dehydrogenase oxidation.
- Its glucuronide conjugate, 3α-androstanediol glucuronide, is a widely used clinical serum marker of peripheral 5α-reductase and androgen activity in conditions such as hirsutism.
Mechanism
3α-Androstanediol is the endpoint of the androgen backdoor and reductive pathway: testosterone is converted by 5α-reductase to dihydrotestosterone (DHT), and DHT is then reduced at the 3-keto position by 3α-hydroxysteroid dehydrogenase (3α-HSD, members of the aldo-keto reductase AKR1C family and a microsomal isoform) to yield 3α-androstanediol. This 3α-reduction is reversible; oxidative 3α-HSD activity regenerates DHT, so the functions as a bidirectional reservoir that buffers local DHT concentrations in brain and peripheral tissue.
The 3α-hydroxyl configuration is pharmacologically decisive: it abolishes most androgen-receptor binding while conferring allopregnanolone-like activity at the -A receptor. Mechanistically, 3α-androstanediol is a positive modulator (PAM) of GABA-A receptors, binding the transmembrane neurosteroid site to GABA-gated chloride flux, prolong channel open time, and (at higher concentrations) directly gate the channel.
It enhances both (phasic) inhibition and extrasynaptic, δ-subunit-containing (tonic) inhibition, the latter being the substrate most relevant to its antiseizure action in status epilepticus models. Reddy and colleagues demonstrated in patch-clamp and rodent seizure work that this potentiation, rather than androgen-receptor signaling, accounts for the anticonvulsant and anxiolytic phenotype.
A secondary target is receptor beta (ERβ), at which 3α-androstanediol acts as a weak ; ERβ signaling in the is implicated in its pro-cognitive, antiseizure, and neuroprotective effects. The parent DHT and the progesterone-derived allopregnanolone are its closest functional relatives, and its circulating glucuronide conjugate (3α-androstanediol glucuronide) is a clinical index of peripheral 5α-reductase activity.
receptor fingerprint
-A receptor (neurosteroid site)Positive allosteric modulation of GABA-gated chloride current
Extrasynaptic δ-subunit -A receptorPotentiation of tonic inhibition
Dihydrotestosterone poolReversible interconversion via 3α-HSD
Extrasynaptic / tonic -A receptorsEnhancement of inhibitory conductance characteristic of neurosteroid modulators
receptor beta (ERβ)Weak agonism
Weak agonism, largely via reconversion to DHT
receptor beta (via 3β-diol interconversion)Indirect partial agonism after epimerization to 3-beta-diol
Safetyrisks and cautions, not medical advice
As an endogenous metabolite, 3α-androstanediol is a normal constituent of human physiology and its circulating conjugate is routinely measured in clinical androgen assays. However, its profile as an administered agent is essentially uncharacterized in humans; the available pharmacology comes from rodent and in vitro studies. As a GABA-A positive allosteric modulator it carries the theoretical liabilities of that class, including sedation, motor impairment, and the potential for tolerance and withdrawal seen with other neurosteroid modulators. A distinctive consideration is its reversible interconversion with dihydrotestosterone, meaning exogenous exposure could raise active androgen levels. It is not an approved therapeutic, and it should be regarded as a research compound rather than a validated supplement.
History
Interest in 3α-androstanediol as a neuroactive steroid grew from behavioral work by Frye and colleagues in the mid 1990s, who showed that the compound modulated sexual receptivity and promoted GABA-stimulated chloride flux through actions in the hypothalamus and preoptic area. In the 2000s Doodipala Reddy and coworkers established it as a bona fide anticonvulsant neurosteroid, developing mass-spectrometric assays to quantify it, demonstrating that it raises seizure threshold, and showing that testosterone's modulation of seizure susceptibility is mediated by its conversion to 3α-androstanediol and to 17β-estradiol.
In 2010 the same group provided direct electrophysiological evidence that 3α-androstanediol is a positive allosteric modulator of GABA-A receptors, cementing its status as the androgen-derived analog of allopregnanolone. Parallel work by Frye, Edinger, and colleagues linked its cognitive and antiseizure actions partly to estrogen receptor beta.
Reputation
Within neuroendocrinology and epilepsy research 3α-androstanediol is well regarded as the canonical androgen-derived GABAergic neurosteroid and as a key to understanding how testosterone shapes seizure threshold, anxiety, and mood in males. Outside that specialist literature it is obscure: it is not a consumer nootropic or a marketed supplement, and it is far less discussed than allopregnanolone or its clinical analog brexanolone. Its reputation is therefore that of an important endogenous mechanistic mediator and research tool rather than a therapeutic product.
Subjective profileweighing the evidence above
Better understood as biology than as something to take; it is the endogenous metabolite that probably carries much of testosterone's calming, anticonvulsant side. As an administered compound it is essentially uncharacterized in humans, and it brings the tolerance and withdrawal liabilities of any GABA-A modulator.
Resources
This entry is here for reference.
Research
- 1996first citedBehavioral effects of 3 alpha-androstanediol. I: Modulation of sexual receptivity and promotion…
- 2004most active year6 papers
- 2022most recentNeurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocr…
- 1.The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptors.
- 2.Anticonvulsant activity of the testosterone-derived neurosteroid 3alpha-androstanediol.
- 3.Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol.
- 4.A high-performance liquid chromatography-tandem mass spectrometry assay of the androgenic neurosteroid 3alpha-androstanediol (5alpha-androstane-3alpha,17beta-diol) in plasma.
- 5.Mass spectrometric assay and physiological-pharmacological activity of androgenic neurosteroids.
- 6.Behavioral effects of 3 alpha-androstanediol. I: Modulation of sexual receptivity and promotion of GABA-stimulated chloride flux.
- 7.Behavioral effects of 3 alpha-androstanediol. II: Hypothalamic and preoptic area actions via a GABAergic mechanism.
- 8.Extrasynaptic γ-aminobutyric acid type A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures.
- 9.Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability.
- 10.Neurosteroids: endogenous role in the human brain and therapeutic potentials.
- 11.Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women.
- 12.Antiseizure effects of 3alpha-androstanediol and/or 17beta-estradiol may involve actions at estrogen receptor beta.
36 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
Is 3α-androstanediol a hormone or a neurosteroid?
It is both. Structurally it is an androgen metabolite (a steroid hormone derivative of DHT), but functionally in the brain it behaves as a neurosteroid, potentiating GABA-A receptors much like allopregnanolone rather than acting through classic androgen signaling.
How is it different from allopregnanolone?
Both are potent GABA-A positive allosteric modulators with a 3α-hydroxy, 5α-reduced configuration, but allopregnanolone is derived from progesterone whereas 3α-androstanediol is derived from testosterone via DHT. They are often described as the progesterone-derived and androgen-derived members of the same neurosteroid family.
Does it have androgenic (masculinizing) effects?
Only weakly and mostly indirectly. Its affinity for the androgen receptor is low, but because its formation from DHT is reversible, it can be oxidized back to DHT and thereby serve as an androgen reservoir.
Can you take it as a supplement?
It is not marketed as a mainstream oral supplement and has no established human dosing regimen; nearly all evidence comes from endogenous physiology and animal research.
Why is it relevant to epilepsy and anxiety research?
By enhancing both phasic and tonic GABA-A inhibition it raises seizure threshold and reduces anxiety-like behavior in rodents, and it is thought to help explain sex differences and hormonal fluctuations in seizure susceptibility.
Adverse effects
- Sedation and motor impairment at high GABAergic doses in animal studies
- Potential tolerance, dependence, and withdrawal phenomena common to GABA-A modulating neurosteroids
Notes and cautions
- Reversible back-conversion to dihydrotestosterone, an active androgen
- Human safety and side-effect profile remains largely uncharacterized